Market Overview :
The global single-use bioreactors market reached a value of US$ 2.54 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 6.23 Billion by 2027, exhibiting a CAGR of 15.50% during 2022-2027.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/single-use-bioreactor-market/requestsample
A single-use bioreactor (SUB) is a disposable bioreactor that relies on a disposable bag instead of a culture vessel made of stainless steel or glass. It consists of a plastic lining in contact with the cell culture encased within a more permanent structure. SUB is environment-friendly, flexible, easy to use and install, and hardly needs utility requirements such as steam and water. It also minimizes labor costs, decreases the rate of cross-contamination, and terminates the need for validation issues and cleaning processes. Consequently, SUB finds extensive application across contract research organizations (CROs) and contract manufacturing organizations (CMOs).
Single-Use Bioreactors Market Trends and Drivers:
The market is primarily driven by the significant growth of the biopharmaceutical industry. In the pharmaceutical industry, SUBs are utilized for media and buffer preparation, cell harvesting, filtration, purification, and virus inactivation. Apart from this, SUBs are low maintenance, cost-effective and reduce sterilization time.
Due to this, they are used in academic and commercial-scale laboratories for drug discovery and vaccine development. Besides this, key companies are extensively investing in enhancing the stirring mechanism, sensor systems, designs, and film technology of single-use bioreactors, which is fueling the market growth.
Furthermore, innovation in products, along with various mergers and acquisitions (M&A) undertaken by leading players to expand the consumer base and increasing geographical presence, is also expected to escalate the demand for SUBs in the upcoming years.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://bit.ly/374Ms2g
|Catheter-Directed Thrombolysis Device Market Report Scope|
|Market size value in 2021||US$ 2.54 Billion|
|Market forecast in 2027||US$ 6.23 Billion|
|Growth Rate||CAGR of 15.50% from 2022 to 2027|
|Base year for estimation||2021|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
|Segments covered||product type, type, cell type, molecule type and end user|
|Regional scope||North America, Europe, Asia-Pacific, Europe, Latin America, Middle East and Africa|
|Key companies profiled||ABEC Inc., Cellexus, Celltainer Biotech B.V., CESCO Bioengineering Co. Ltd., Distek Inc., Eppendorf SE, General Electric Company, Getinge AB, Merck KGaA, Pall Corporation (Danaher Corporation), PBS Biotech Inc., Sartorius AG and Thermo Fisher Scientific Inc.|
|Market Dynamics||Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,|
|Customization preview||If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.|
Global Single-Use Bioreactors Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these major key players include:
- ABEC Inc.,
- Celltainer Biotech B.V.,
- CESCO Bioengineering Co. Ltd.,
- Distek Inc.,
- Eppendorf SE,
- General Electric Company,
- Getinge AB,
- Merck KGaA,
- Pall Corporation (Danaher Corporation),
- PBS Biotech Inc.,
- Sartorius AG
- Thermo Fisher Scientific Inc.
Inquire Before Buying : https://www.imarcgroup.com/request?type=report&id=5151&flag=F
The report has segmented the market on the basis of region, product type, type, cell type, molecule type and end user.
Breakup by Product Type:
- Single-use Bioreactor Systems
- Media Bags
- Filtration Assemblies
Breakup by Type:
- Stirred-tank Bioreactors
- Wave-induced Bioreactors
- Bubble-column Bioreactors
Breakup by Cell Type:
- Mammalian Cell
Breakup by Molecule Type:
- Monoclonal Antibodies
- Stem Cells
- Recombinant Proteins
Breakup by End User:
- Pharmaceutical and Biopharmaceutical Companies
- Contract Research Organizations
- Academic and Research Institutes
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800